marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2024
added 02-19-2025
Krystal Biotech Financial Ratios 2011-2025 | KRYS
Annual Financial Ratios Krystal Biotech
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
56.3 | 392.8 | -14.3 | -20.3 | -46.1 | -44.0 | -23.5 | -6.8 | - | - | - | - | - | - |
P/S |
17.3 | 84.7 | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
3.1 | 0.4 | -5.5 | -3.1 | -1.7 | -1.2 | -1.0 | -1.5 | -1.3 | - | - | - | - | - |
EV (Enterprise Value) |
4.79 B | 3.98 B | 1.87 B | 1.1 B | 1.23 B | 658 M | 155 M | 4.87 M | -30 K | - | - | - | - | - |
EBITDA per Share |
2.51 | -3.86 | -5.59 | -2.99 | -1.66 | -1.34 | -1.05 | -0.886 | - | - | - | - | - | - |
EV/EBITDA |
-16.6 | -35.4 | -30.6 | -12.9 | -0.9 | - | - | - | - | - | - | |||
PEG |
-54.53 | 10.47 | -0.3 | - | -0.62 | -1.86 | 0.68 | -0.01 | - | - | - | - | - | - |
P/B |
5.3 | 5.5 | 3.8 | 2.4 | 5.1 | 4.1 | 2.3 | 1.1 | - | - | - | - | - | - |
P/CF |
40.7 | -48.4 | -19.9 | -29.4 | -56.8 | -33.4 | -21.9 | -13.1 | - | - | - | - | - | - |
ROE % |
9.42 | 1.40 | -26.80 | -11.72 | -11.01 | -9.41 | -9.62 | -16.01 | - | - | - | - | - | - |
ROA % |
8.44 | 1.34 | -25.06 | -11.11 | -10.35 | -9.13 | -9.38 | -15.80 | - | - | - | - | - | - |
ROCE % |
6.94 | -14.09 | -27.80 | -11.50 | -11.30 | -10.73 | -10.50 | -9.65 | - | - | - | - | - | - |
Current Ratio |
9.6 | 20.6 | 15.4 | 19.1 | 16.6 | 58.9 | 43.4 | 78.0 | - | - | - | - | - | - |
DSO |
92.2 | 151.3 | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
92.2 | 151.3 | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
92.2 | 151.3 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Krystal Biotech
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.95 | 0.54 | 0.03 | - | 2.88 | -1.25 | -1.76 | - | -1.17 | -1.1 | -1.99 | - | -0.7 | -0.74 | -0.74 | - | -0.49 | -0.37 | -0.31 | - | -0.25 | -0.37 | -0.29 | - | -0.26 | -0.22 | -0.21 | - | -1.26 | -0.22 | -0.14 | - | -8.48 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
0.83 | 0.36 | -0.19 | - | -0.88 | -1.38 | -1.86 | - | -1.2 | -1.11 | -1.96 | - | -0.62 | -0.68 | -0.65 | - | -0.42 | -0.33 | -0.32 | - | -0.27 | -0.37 | -0.32 | - | -0.28 | -0.24 | -0.22 | - | -0.5 | -0.2 | -0.13 | - | -8.48 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
15.72 | 23.34 | 16.39 | -3.66 | -9.18 | -25.38 | -25.32 | -19.66 | -23.47 | -21.77 | -20.66 | -11.40 | -14.69 | -14.16 | -12.59 | -7.46 | -9.56 | -8.38 | -8.67 | -6.77 | -9.20 | -9.53 | -8.90 | -6.34 | -17.00 | -25.23 | -24.75 | -13.19 | -124.61 | -225.37 | -223.84 | -111.42 | -111.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
14.79 | 22.24 | 15.69 | -3.16 | -8.33 | -23.73 | -23.55 | -17.95 | -21.41 | -19.69 | -18.70 | -10.71 | -13.81 | -13.44 | -11.95 | -7.01 | -9.05 | -8.00 | -8.36 | -6.57 | -8.94 | -9.27 | -8.67 | -6.18 | -16.20 | -23.83 | -23.39 | -12.51 | -27.27 | -32.01 | -30.50 | -14.76 | -14.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-0.72 | -6.69 | -13.54 | -19.24 | -25.05 | -27.43 | -26.75 | -20.11 | -23.95 | -21.97 | -20.74 | -11.08 | -14.40 | -13.88 | -12.34 | -7.73 | -10.36 | -9.68 | -10.20 | -7.85 | -10.47 | -10.47 | -9.73 | -6.80 | -11.03 | -12.63 | -11.92 | -6.62 | -118.03 | -225.22 | -223.78 | -111.42 | -111.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
10.2 | 11.7 | 15.8 | 20.6 | 23.0 | 22.1 | 12.6 | 15.4 | 16.2 | 14.3 | 9.0 | 19.1 | 10.5 | 17.7 | 35.8 | 16.6 | 16.6 | 16.6 | 16.6 | 34.2 | 34.2 | 34.2 | 34.2 | 40.2 | 40.2 | 40.2 | 40.2 | 78.3 | 21.3 | 78.3 | 78.3 | 1.1 | 1.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
109.1 | 97.2 | 89.2 | - | 49.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
109.1 | 97.2 | 89.2 | - | 49.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
109.1 | 97.2 | 89.2 | - | 49.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency